ReviewFrontiers in pediatrics2026
Research progress on the role of bile acid metabolism in intestinal epithelial cell injury in necrotizing enterocolitis.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing enterocolitis (NEC) is a critical gastrointestinal emergency frequently occurring in premature infants. Its etiology is not yet fully elucidated, which makes clinical diagnosis and treatment challenging. In recent years, the core role of bile acid metabolism dysregulation and the signaling pathways involved in the pathogenesis of NEC have become increasingly prominent. This review focuses on the core characteristics of abnormal bile acid composition and enterohepatic circulation imbalance in children with NEC, analyzing the bidirectional regulatory relationship between bile acids and intestinal microbiota. It also emphasizes the mechanism by which excessive activation of Farnesoid X receptor drives the occurrence and development of NEC by damaging the intestinal epithelial barrier, inducing ferroptosis in intestinal epithelial cells, and exacerbating intestinal immune inflammation. Intestinal epithelial cells are recognized as the central integrators and primary targets of bile acid dysregulation and intestinal microbiota dysbiosis in NEC pathogenesis. This review systematically summarizes relevant research progress and explores the potential value and clinical translational prospects of novel prevention and treatment strategies targeting bile acid metabolism and signaling pathways, providing theoretical support for optimizing NEC diagnosis and treatment, and improving the prognosis of premature infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.